OPDIVO (E.R. Squibb & Sons, L.L.C.)
Welcome to the PulseAid listing for the OPDIVO drug offered from E.R. Squibb & Sons, L.L.C.. This Programmed Death Receptor-1 Blocking Antibody [EPC],Programmed Death Receptor-1-directed Antibody Interactions [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | E.R. Squibb & Sons, L.L.C. |
| NON-PROPRIETARY NAME: | nivolumab |
| SUBSTANCE NAME: | NIVOLUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Programmed Death Receptor-1 Blocking Antibody [EPC],Programmed Death Receptor-1-directed Antibody Interactions [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2014-12-22 |
| END MARKETING DATE: | 0000-00-00 |
OPDIVO HUMAN PRESCRIPTION DRUG Details:
| Item Description | OPDIVO from E.R. Squibb & Sons, L.L.C. |
| LABELER NAME: | E.R. Squibb & Sons, L.L.C. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2014-12-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0003-3772_aeb6b7b2-544b-430b-a736-9f8b08d19c6c |
| PRODUCT NDC: | 0003-3772 |
| APPLICATION NUMBER: | BLA125554 |
Other NIVOLUMAB Pharmaceutical Manufacturers / Labelers:
